TELA Bio Inc (TELA)
3.01
+0.12
(+4.15%)
USD |
NASDAQ |
Nov 22, 16:00
3.005
0.00 (0.00%)
After-Hours: 20:00
TELA Bio Cash from Financing (Quarterly): 0.098M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.098M |
June 30, 2024 | -0.005M |
March 31, 2024 | 0.056M |
December 31, 2023 | 0.022M |
September 30, 2023 | 0.071M |
June 30, 2023 | 46.41M |
March 31, 2023 | -0.235M |
December 31, 2022 | -0.219M |
September 30, 2022 | 34.57M |
June 30, 2022 | 6.648M |
March 31, 2022 | -0.146M |
December 31, 2021 | 0.174M |
Date | Value |
---|---|
September 30, 2021 | 0.259M |
June 30, 2021 | 0.116M |
March 31, 2021 | 0.036M |
December 31, 2020 | 0.046M |
September 30, 2020 | -0.279M |
June 30, 2020 | 45.16M |
March 31, 2020 | -0.514M |
December 31, 2019 | 51.10M |
September 30, 2019 | 2.261M |
June 30, 2019 | 11.68M |
March 31, 2019 | 0.484M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.514M
Minimum
Mar 2020
51.10M
Maximum
Dec 2019
9.168M
Average
0.0635M
Median
Cash from Financing (Quarterly) Benchmarks
Cutera Inc | -0.419M |
IRIDEX Corp | 2.823M |
Stereotaxis Inc | 0.08M |
Electromed Inc | -4.467M |
Myomo Inc | -0.1995M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -8.983M |
Cash from Investing (Quarterly) | -0.122M |
Free Cash Flow | -46.04M |
Free Cash Flow Per Share (Quarterly) | -0.3686 |
Free Cash Flow to Equity (Quarterly) | -9.258M |
Free Cash Flow Yield | -62.15% |